{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:03:50Z","timestamp":1790402630894,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Aim for the Top University Plan","award":["103AC-P504"],"award-info":[{"award-number":["103AC-P504"]}]},{"name":"TCVGH-NYMU Joint Research Program","award":["TCVGH-YM1030202"],"award-info":[{"award-number":["TCVGH-YM1030202"]}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-3011-B-010-001-1-4-2"],"award-info":[{"award-number":["MOST 104-3011-B-010-001-1-4-2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154672","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T13:58:33Z","timestamp":1462283913000},"page":"e0154672","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins"],"prefix":"10.1371","volume":"11","author":[{"given":"Wei-Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne H-H","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chi","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shyuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jane","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pey-Jium","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Na","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"DP Bartel","year":"2004","journal-title":"Cell"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13130-X","article-title":"Small RNAs: classification, biogenesis, and function","volume":"19","author":"VN Kim","year":"2005","journal-title":"Mol Cell"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"RM O\u2019Connell","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.molcel.2006.01.031","article-title":"Short RNAs repress translation after initiation in mammalian cells","volume":"21","author":"CP Petersen","year":"2006","journal-title":"Mol Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1101\/sqb.2011.76.011049","article-title":"MicroRNAs in metabolism and metabolic diseases","volume":"76","author":"V Rottiers","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MED.0b013e32833727a1","article-title":"MicroRNAs in atherosclerosis and lipoprotein metabolism","volume":"17","author":"KC Vickers","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7385","key":"ref7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"A Lujambio","year":"2012","journal-title":"Nature"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2013.86","article-title":"Circulating microRNAs as novel biomarkers for diabetes mellitus","volume":"9","author":"C Guay","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1373\/clinchem.2013.204917","article-title":"MicroRNAs in the Atheroclerotic Plaque","volume":"59","author":"E Raitoharju","year":"2013","journal-title":"Clin Chem"},{"issue":"5985","key":"ref10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"KJ Rayner","year":"2010","journal-title":"Science"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3748\/wjg.v21.i2.511","article-title":"miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease","volume":"21","author":"Q Xu","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0033-1341516","article-title":"Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes","volume":"121","author":"NE Corral-Fern\u00e1ndez","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9491","key":"ref13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"KG Alberti","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/CIRCRESAHA.115.306052","article-title":"Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL","volume":"116","author":"JW Heinecke","year":"2015","journal-title":"Circ Res"},{"issue":"25","key":"ref15","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2174\/0929867321666140303153430","article-title":"Metabolism of HDL and its regulation","volume":"21","author":"D Kardassis","year":"2014","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/138920112799095365","article-title":"ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins: Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?","volume":"13","author":"C Buechler","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI33296","article-title":"Cholesterol in islet dysfunction and type 2 diabetes","volume":"118","author":"LR Brunham","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2009.03.011","article-title":"The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes","volume":"1791","author":"C Tang","year":"2009","journal-title":"Biochim Biophy Acta"},{"issue":"36","key":"ref19","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABCA1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"P Costet","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cvr\/cvu140","article-title":"microRNAs and HDL life cycle","volume":"103","author":"A Canfr\u00e1n-Duque","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jcb.24478","article-title":"Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages","volume":"114","author":"YC Chang","year":"2013","journal-title":"J Cell Biochem"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20150027","article-title":"Cellular and molecular mechanisms of statins: an update on pleiotropic effects","volume":"129","author":"M Satoh","year":"2015","journal-title":"Clin Sci"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2014.12.014","article-title":"Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients","volume":"238","author":"E Oikonomou","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570161043385475","article-title":"Non-lipid effects of statins: emerging new indications","volume":"2","author":"A Yildirir","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: A review of proposed mechanisms","volume":"63","author":"M Brault","year":"2014","journal-title":"Metabolism"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0735-1097(98)00300-3","article-title":"Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin","volume":"32","author":"AS Brown","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref27","first-page":"406","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"82","author":"J Pincus","year":"1998","journal-title":"Am J Cardiol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1254\/jphs.FP0072403","article-title":"Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes","volume":"107","author":"A Takaguri","year":"2008","journal-title":"J Pharmacol Sci"},{"issue":"6821","key":"ref29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"ED Abel","year":"2001","journal-title":"Nature"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.clinthera.2008.05.017","article-title":"A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance","volume":"30","author":"J Sasaki","year":"2008","journal-title":"Clin Ther"},{"issue":"S1","key":"ref31","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-2840-12-S1-S2","article-title":"Pitavastatin in cardiometabolic disease: therapeutic profile","volume":"12","author":"L Masana","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"9753","key":"ref32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Baigent","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes:a meta-analysis","volume":"32","author":"SN Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort","volume":"58","author":"H Cederberg","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2015.03.047","article-title":"Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes","volume":"184","author":"JY Park","year":"2015","journal-title":"Int J Cardiol"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus","volume":"111","author":"EP Navarese","year":"2013","journal-title":"Am J Cardiol"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"D Preiss","year":"2011","journal-title":"JAMA"},{"issue":"9716","key":"ref38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"N Sattar","year":"2010","journal-title":"Lancet"},{"key":"ref39","unstructured":"FDA drug safety communication: important safety label changes to cholesterol-lowering statin drugs. US Food and Drug Administration. 2012."},{"issue":"5985","key":"ref40","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"238","author":"SH Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/emmm.201100191","article-title":"MicroRNA therapeutics in cardiovascular medicine","volume":"4","author":"T Thum","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"7369","key":"ref42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in nonhuman primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"KJ Rayner","year":"2011","journal-title":"Nature"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"KJ Rayner","year":"2011","journal-title":"J Clin Invest"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"e15263","DOI":"10.1371\/journal.pone.0015263","article-title":"A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells","volume":"5","author":"FM Marim","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1194\/jlr.M024471","article-title":"Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages","volume":"53","author":"YC Chang","year":"2012","journal-title":"J Lipid Res"},{"issue":"9\u201310","key":"ref46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2119\/molmed.2010.00004","article-title":"ATP-Binding Membrane Cassette Transporter A1 (ABCA1): A Possible Link between Inflammation and Reverse Cholesterol Transport","volume":"16","author":"K Yin","year":"2010","journal-title":"Mol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"KJ Moore","year":"2011","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"P Libby","year":"2011","journal-title":"Nature"},{"issue":"40","key":"ref49","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo","volume":"107","author":"T Horie","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5985","key":"ref50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/BJ20060914","article-title":"SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR","volume":"400","author":"J Wong","year":"2006","journal-title":"Biochem J"},{"issue":"15","key":"ref52","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/MCB.00016-13","article-title":"MicroRNA 33 regulates glucose metabolism","volume":"33","author":"CM Ram\u00edrez","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"HS Kim","year":"2010","journal-title":"Cell Metab"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"e22142","DOI":"10.1371\/journal.pone.0022142","article-title":"Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function","volume":"6","author":"DC Patel","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1096\/fj.10-179267","article-title":"Cholesterol regulation of receptor-interacting protein 140 <italic>via<\/italic> microRNA-33 in inflammatory cytokine production","volume":"25","author":"PC Ho","year":"2011","journal-title":"FASEB J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T01:28:46Z","timestamp":1718501326000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154672"}},"subtitle":[],"editor":[{"given":"Nicola","family":"Amodio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154672","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]}}}